Literature DB >> 19481035

Feline calicivirus infection. ABCD guidelines on prevention and management.

Alan D Radford1, Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Tim Gruffydd-Jones, Katrin Hartmann, Margaret J Hosie, Albert Lloret, Hans Lutz, Fulvio Marsilio, Maria Grazia Pennisi, Etienne Thiry, Uwe Truyen, Marian C Horzinek.   

Abstract

OVERVIEW: Feline calicivirus (FCV) is a highly variable virus. More severe, systemic forms of FCV infection have been observed recently. INFECTION: Sick, acutely infected or carrier cats shed FCV in oronasal and conjunctival secretions. Infection occurs mainly through direct contact. DISEASE SIGNS: The main clinical signs are oral ulcers, upper respiratory signs and a high fever. Feline calicivirus may be isolated from nearly all cats with chronic stomatitis or gingivitis. Cats with 'virulent systemic FCV disease' variably show pyrexia, cutaneous oedema, ulcerative lesions on the head and limbs, and jaundice. Mortality is high and the disease is more severe in adult cats. DIAGNOSIS: Diagnosis of FCV can be achieved by virus isolation or reverse-transcriptase PCR. Viral RNA can be detected in conjunctival and oral swabs, blood, skin scrapings or lung tissue using PCR. Positive PCR results should be interpreted with caution, as these may be a consequence of low-level shedding by persistently infected carriers. The diagnosis of virulent systemic FCV disease relies on clinical signs and isolation of the same strain from the blood of several diseased cats. DISEASE MANAGEMENT: Supportive therapy (including fluid therapy) and good nursing care are essential. Anorexic cats should be fed highly palatable, blended or warmed food. Mucolytic drugs (eg, bromhexine) or nebulisation with saline may offer relief. Broad-spectrum antibiotics may be administered to prevent secondary bacterial infections. Feline calicivirus can persist in the environment for about 1 month and is resistant to many common disinfectants. VACCINATION RECOMMENDATIONS: Two injections, at 9 and 12 weeks of age, are recommended, followed by a first booster 1 year later. In high-risk situations, a third vaccination at 16 weeks is recommended. Boosters should be given every 3 years. However, cats in high-risk situations should be revaccinated annually. Cats that have recovered from caliciviral disease are probably not protected for life, particularly if infected with different strains. Vaccination of these cats is still recommended.

Entities:  

Mesh:

Year:  2009        PMID: 19481035     DOI: 10.1016/j.jfms.2009.05.004

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  35 in total

1.  Histologic and molecular correlation in shelter cats with acute upper respiratory infection.

Authors:  Rachel E Burns; Denae C Wagner; Christian M Leutenegger; Patricia A Pesavento
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

2.  Establishment and application of ERA-LFD method for rapid detection of feline calicivirus.

Authors:  Di Liu; Yating Zheng; Yupeng Yang; Xinyan Xu; Hongtao Kang; Qian Jiang; Mingfa Yang; Liandong Qu; Jiasen Liu
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-28       Impact factor: 4.813

3.  Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydia felis, and Bordetella bronchiseptica in a population of shelter cats on Prince Edward Island.

Authors:  Julie Walter; Peter Foley; Carmencita Yason; Raphael Vanderstichel; Anne Muckle
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

4.  Large-scale spatial and temporal genetic diversity of feline calicivirus.

Authors:  Karen P Coyne; Rob M Christley; Oliver G Pybus; Susan Dawson; Rosalind M Gaskell; Alan D Radford
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

5.  A novel Filobacterium sp can cause chronic bronchitis in cats.

Authors:  Martina Načeradská; Sona Pekova; Patrizia Danesi; Tommaso Furlanello; Roberta Calleo; Patricia Martin; Fumio Ike; Richard Malik
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

6.  Discovery and genomic characterization of noroviruses from a gastroenteritis outbreak in domestic cats in the US.

Authors:  Pierfrancesco Pinto; Qiuhong Wang; Ning Chen; Edward J Dubovi; Joshua B Daniels; Laurie M Millward; Canio Buonavoglia; Vito Martella; Linda J Saif
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

7.  True versus false parasite interactions: a robust method to take risk factors into account and its application to feline viruses.

Authors:  Eléonore Hellard; Dominique Pontier; Frank Sauvage; Hervé Poulet; David Fouchet
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

Review 8.  Translational Control during Calicivirus Infection.

Authors:  Elizabeth Royall; Nicolas Locker
Journal:  Viruses       Date:  2016-04-20       Impact factor: 5.048

9.  Expression of the NS5 (VPg) Protein of Murine Norovirus Induces a G1/S Phase Arrest.

Authors:  Colin Davies; Vernon K Ward
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

10.  Protective Efficacy of the Calicivirus Valency of the Leucofeligen Vaccine against a Virulent Heterologous Challenge in Kittens.

Authors:  Cynthia Lesbros; Virginie Martin; Wojciech Najbar; Annaele Sanquer; David McGahie; Hyone-Myong Eun; Sylvie Gueguen
Journal:  Vet Med Int       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.